Filing Details

Accession Number:
0001209191-17-054199
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-27 21:43:30
Reporting Period:
2017-09-25
Accepted Time:
2017-09-27 21:43:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1422772 Susan Helen Kim C/O Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Evp, Business Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-25 6,000 $0.00 24,864 No 4 A Direct
Common Stock Disposition 2017-09-25 3,171 $179.66 21,693 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Reflects the correction of an error in the total shares held, which was incorrectly reported in the Reporting Person's Form 4 filed August 16, 2016.
  2. The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.